Needham Reiterates Buy Rating on Acadia Pharmaceuticals, Keeps $35 Target
Needham reiterated its Buy rating and $35 price target on Acadia Pharmaceuticals. The target implies 83.1% upside from the Oct. 16 close of $19.12.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.